SEOUL, South Korea, Feb. 13, 2025 /PRNewswire/ -- DAAN Biotherapeutics, a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies, has signed an exclusive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback